An address system in the vasculature of normal tissues and tumors

Annual Review of Immunology

Volumn 18, Issue , 2000, Pages 813-827

  Ruoslahti, E ^a   Rajotte, D ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

Angiogenesis; Endothelial cells; Homing; Metastasis; Peptides

Indexed keywords

DOXORUBICIN; HOMING RECEPTOR;

ANGIOGENESIS; DRUG TARGETING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEQUENCE ANALYSIS; TISSUE SPECIFICITY; TUMOR VASCULARIZATION; VASCULARIZATION;

ANIMALS; BIOLOGICAL MARKERS; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; HUMANS; LYMPHOID TISSUE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0034082218     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.18.1.813     Document Type: Review

References (82)

1. Butcher EC, Picker LJ. 1996. Lymphocyte homing and homeostasis. Science 272:60-66
2. Lasky LA. 1992. Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 258:964-69
3. Salmi M, Jalkanen S. 1997. How do lymphocytes know where to go: current concepts and enigmas of lymphocyte homing. Adv. Immunol. 64:139-218
4. Springer TA. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301-4
5. Johnson RC, Augustin-Voss HG, Zhu D, Pauli BU. 1991. Endothelial cell membrane vesicles in the study of organ preference of metastasis. Cancer Res. 51:394-99
6. Auerbach R, Lu WC, Pardon E, Gumkowski F, Kaminska G, Kaminski M. 1987. Specificity of adhesion between murine tumor cells and capillary endothelium: an in vitro correlate of preferential metastasis in vivo. Cancer Res. 47:1492-96
7. Caplan AI. 1991. Mesenchymal stem cells. J. Orthopaedic Res. 9:641-50
8. Asahara T, Murohara T, Sullivan M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. 1997. Isolation of putative endothelial cells for angiogenesis. Science 275:964-67
9. Pereira RF, O'HaraMD, Laptev AV, Halford KW, Pollard MD, Class R, Simon D, Livezey K, Prockop DJ. 1998. Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc. Nat. Acad. Sci. USA 95:1142-47
10. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-47
11. Augustin HG, Kozian DH, Johnson RC. 1994. Differentiation of endothelial cells: analysis of the constitutive and activated endothelial cell phenotypes. BioEssays 16:901-6
12. Borsum T, Hagen I, Henriksen T, Carlander B. 1982. Alterations in the protein composition and surface structure of human endothelial cells during growth in primary culture. Atherosclerosis 44:367-78
13. Bono DP, Green C. 1984. The adhesion of different cell types to cultured vascular endothelium: effects of culture density and age. Br. J. Exp. Pathol. 65:145-54
14. Ghitescu L D, Crine P, Jacobson BS. 1997. Antibodies specific to the plasma membrane of rat lung microvascular endothelium. Exp. Cell Res. 232:47-55
15. Jacobson BS, Stolz DB, Schnitzer JE. 1996. Identification of endothelial cellsurface proteins as targets for diagnosis and treatment of disease. Nat. Med. 2:482-84
16. Ponder BAJ, Wilkinson MM. 1983. Organ-related differences in binding of Dolichos biflorus agglutinin to vascular endothelium. Dev. Biol. 96: 535-41
17. Belloni, PN, Nicolson GL. 1988. Differential expression of cell surface glycoproteins on various organ-derived microvascular endothelia and endothelial cultures. J. Cell. Physiol. 136:398-410
18. Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JCR, Trent JM, Staudt LM, Hudson J Jr, Boguski MS, Lashkari D, Shalon D, Botstein D, Brown PO. 1999. The transcriptional program in the response of human fibroblasts to serum. Science 283:83-87
19. Alon U, Barkai N, Notterman DA, Gish K, Ybarra S, Mack D, Levine AJ. 1999. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 96:6745-50
20. Pasqualini R, Ruoslahti E. 1996. Organ targeting in vivo using phage display peptide libraries. Nature 380:364-66
21. Arap W, Pasqualini R, Ruoslahti E. 1998. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279:377-80.
22. Rajotte D, Arap W, Hagedorn M, Koivunen E, Pasqualini R, Ruoslahti E. 1998. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J. Clin. Invest. 102:430-37
23. Smith GP, Scott JK. 1993. Libraries of peptides and proteins displayed on filamentous phage. Meth. Enzymol. 217: 228-57
24. Burritt JB, Bond CW, Doss KW, Jesaitis AJ. 1996. Filamentous phage display of oligopeptide libraries. Analyt. Biochem. 238:1-13
25. Cwirla S.E, Peters EA, Barrett RW, Dower WJ. 1990. Peptides on phage: a vast library of peptides for identifying ligands. Proc. Natl. Acad. Sci. USA 87:6378-82
26. Wrighton N C, Farrell FX, Chang R, Kashyap AK, Barbone FP, Mulcahy LS, Johnson DL, Barrett RW, Jolliffe LK, Dower WJ. 1996. Small peptides as potent mimetics of the protein hormone erythropoietin. Science 273:458-63
27. Koivunen E, Wang B, Dickinson CD, Ruoslahti E. 1994. Peptides in cell adhesion research. Meth. Enzymol. 245:346-69
28. Peletskaya EN, Glinsky VV, Glinsky GV, Deutscher SL, Quinn TP. 1997. Characterization of peptides that bind the tumor-associated Thomsen-Friedenreich antigen selected from bacteriophage display libraries. J. Mol. Biol. 270: 374-84
29. Barry MA, Dower WJ, Johnston SA. 1996. Towards cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Nat. Med. 2:299-305
30. Auerbach R, Alby L, Morrissey LW, Tu M, Joseph J. 1985. Expression of organspecific antigens on capillary endothelial cells. Microvasc. Res. 29:401-11
31. Aird WC, Edelberg JM, Weiler-Guettler H, Simmons WW, Smith TW, Rosenberg RD. 1997. Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment. / Cell. Biol. 138:1117-24
32. Edelberg JM, Aird WC, Wu W, Rayburn H, Mamuya WS, Mercola M, Rosenberg RD 1998. PDGF mediates cardiac microvascular communication. J. Clin. Invest. 102:837-43
33. Maeda K, Abello PA, Abraham MR, Wetzel RC, Robotham JL, Buchman TG. 1995. Endotoxin induces organ-specific endothelial cell injury. Shock 3:46-50
34. Johnson RC, Zhu D, Augustin-Voss HG, Pauli BU. 1993. Lung endothelial dipeptidyl peptidase IV is an adhesion molecule for lung-metastatic rat breast and prostate carcinoma cells. J. Cell biol. 121:1423-32
35. Netland PA, Zetter BR. 1984. Organspecific adhesion of metastatic tumor cells in vitro. Science 224:1113-15
36. Samoylova TI, Smith BF 1999. Elucidation of muscle-binding peptides by phage display screening. Muscle Nerve 22:460-66
37. Rajotte D, Ruoslahti E. 1999. Membrane dipeptidase is the receptor for a lung targeting peptide identified by in vivo phage display. J. Biol. Chem. 274:11593-98
38. Ruoslahti E. 1996. RGD and other recognition sequences for integrins. Annu. Rev. Cell Dev. Biol. 12:697-715
39. Pasqualini R, Koivunen E, Ruoslahti E. 1997. AlphaV integrins as receptors for tumor targeting by circulating ligands. Nat. Biotech. 15:542-46
40. Geter MR, Trigg ME, Merril CR. 1973. Fate of bacteriophage lambda in nonimmune germ-free mice. Nature 246: 221-23
41. EIble RC, Widom J, Gruber AD, AbdelGhany M, Levine R, Goodwin A, Cheng HC, Pauli BU. 1997. Cloning and characterization of lung endothelial cell adhesion molecule-1 suggest it is an endothelial chloride channel. J. Biol. Chem. 272:27853-61
42. Keynan S, Hooper NM, Turner AJ. 1996. Molecular aspects of membrane dipeptidase. In Molecular and Functional Aspects of Membrane Dipeptidase in Zinc Metalloproteases in Health and Disease, ed. NM Hooper, pp. 285-309. London: Taylor & Francis
43. Habib GM, Barrios R, Shi ZZ, Lieberman MW. 1996. Four distinct membranebound dipeptidase RNAs are differentially expressed and show discordant regulation with gamma-glutamyl transpeptidase J. Biol. Chem. 271:16273-80
44. Inamura T, Pardridge WM, Kumagai Y, Black KL. 1994. Differential tissue expression of immunoreactive dehydropeptidase. I, a peptidyl leukotriene metabolizing enzyme. Proslaglandins Leukotrienes Essential Fatty Acids 50: 85-92
45. O'Neil KT, Hoess RH, Jackson SA, Ramachandran NS, Mousa SA, DeGrado WF. 1992. Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library. Proteins 14:509-15
46. Hanahan D, Folkman J. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-64
47. Brooks PC, Clark RA, Cheresh DA. 1994. Requirement of vascular integrin αvβ3 for angiogenesis. Science 264:569-71
48. Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA. 1994. Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79:1157-64
49. Pasqualini R, Bodorova J, Ye S, Hemler ME. 1993. Monoclonal antibodies for study of the structure, function and distribution of β5 containing integrins. J. Cell Sci. 105:101-11
50. Senger DR, Claffey KP, Benes JE, Perruzzi CA, Sergiou AP, Detmar M. 1997. Angiogenesis promoted by vascular endothelial growth factor: regulation through α1β1 and α2β1 integrins. Proc. Natl. Acad. Sci. USA 94:13612-17
51. Koivunen E, Wang B, Ruoslahti E. 1995. Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins. Bio/technology 13:265-70
52. Eliceiri BP, Cheresh DA. 1999. The role of αv integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J. Clin. Invest. 103:1227-30
53. Hammes HP, Brownlee M, Jonczyk A, Sutler A, Preissner KT. 1996. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat. Med. 2:529-33
54. Ferrara N, Davis-Smyth T. 1997. The biology of vascular endothelial growth factor. Endocrine Rev. 18:4-25
55. Hanahan D. 1997. Signaling vascular morphogenesis and maintenance. Science 277:48-50
56. Korpelainen EI, Alitalo K. 1998. Signaling angiogenesis and lymphangiogene-sis.Curr. Opin. Cell Biol. 10:159-64
57. Brekken RA, Huang X, King SW, Thorpe PE. 1998. Vascular endothelial growth factor as a marker of tumor endothelium. Cancer Res. 58:1952-59
58. Jeltsch M, Kaipainen A, Joukov V, Meng XJ, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, Alitalo K. 1997. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423-25
59. Jussila L, Valtola R, Partanen TA, Salven P, Heikkila P, Matikainen MT, Renkonen R, Kaipainen A, Detmar M, Tschachler E, Alitalo R, Alitalo K. 1998. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res. 58:1599-1604
60. Peters KG, Coogan A, Berry D, Marks J, Iglehart JD, Kontos CD, Rao P, Sankar S, Trogan E. 1998. Expression of Tie/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis. Br. J. Cancer 77:51-56
61. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wiegand SJ. 1999. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284:1994-98
62. Pasquale EB. 1997. The Eph family of receptors. Curr. Opin. Cell Biol. 9:608-15
63. Pandey, A, Shao, H, Marks, RM, Polverini PJ, Dixit VM. 1995. Role of B61, the ligand for the Eck receptor tyrosine kinase, inTNF-alpha-induced angiogenesis. Science 268:567-69
64. Yancopoulos GD, Klagsbrun M, Folk-man J. 1998. Vasculogenesis, angiogen-esis, and growth factors: ephrins enter the fray at the border. Cell 93:661-64
65. Adams RH, Wilkinson GA, Weiss C, Diella F, Gale NW, Deutsch U, Risau W, Klein R. 1999. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/ venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 13:295-306
66. Wang HU, Chen ZF, Andersen DJ. 1998. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93:741-53
67. Birkedal-Hansen H. 1995. Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol. 7:728-35
68. Koivunen E, Arap W, Valtanen H, Rainisalo A, Medina OP, Heikkila P, Kantor C, Gahmberg CG, Salo T, Konttinen YT, Sorsa T, Ruoslahti E, Pasqualini R. 1999. Tumor targeting with a selective gelatinase inhibitor. Nat. Biotech. 17:768-74
69. Neri D, Carnemolla B, Nissim A, Leprini A, Querze G, Balza E, Pini A, Tarli L, Halin C, Neri P, Zardi L.Winter G. 1997. Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated flbronectin isoform. Nat. Biotech. 15:1271-75
70. Schlingemann RO, Rietveld FJ, de Waal RM, Ferrone S, Ruiter DJ. 1990. Expres-sion of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds. Am. J. Pathol. 136: 1393-405
71. Schlingemann RO, Oosterwijk E, Wes-seling P, Rietveld FJ, Ruiter DJ. 1996. Aminopeptidase A is a constituent of activated pericytes in angiogenesis. J. Pathol. 179:436-12
72. Grako KA, Stallcup WB. 1995. Participation of the NG2 proteoglycan in rat aortic smooth muscle cell responses to platelet-derived growth factor. Exp. Cell Res. 221:231-40
73. Burg MA, Pasqualini R, Arap W, Ruoslahti E1 Stallcup B. 1999. NG2 proteoglycan-binding peptides home to tumor neovasculature. Cancer Res. 59: 2869-74
74. Breiteneder-Geleff S, Soleiman A, Kowalski H, Horvat R, Amann G, Kriehuber E, Diem K, Weninger W, Tschachler E, Alitalo K, Kerjaschki D. 1999. Angiosarcomas express mixed endothe-lial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am. J. Pathol. 154:385-94
75. Matsuura N, Puzon-McLaughlin W, Irie A, Morikawa Y, Kakudo K, Takada Y. 1996. Induction of experimental bone metastasis in mice by transfection of integrin alpha 4 beta 1 into tumor cells Am. J. Pathol. 148:55-61
76. Cheng HC, Abdel-Ghany M, ElWe RC, Pauli BU. 1998. Lung endothelial dipeptidyl peptidase IV promotes adhesion and metastasis of rat breast cancer cells via tumor cell surface-associated fibronectin. J. Biol. Chem. 273:24207-15
77. Takada A, Ohmori K, Yoneda T, Tsuyuoka K, Hasegawa A, Kiso M, Kannagi R. 1993. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res. 53:354-61
78. Ohyama C, Tsuboi S, Fukuda M. 1999. Dual roles of sialyl Lewis X oligosaccharides in tumor metastasis and rejection by natural killer cells. EMBO J. 18:1516-25
79. Larocca D, Kassner PD, Witte A, Ladner RC, Pierce GF, Baird A. 1999. Gene transfer to mammalian cells using genetically targeted filamentous bacteriophage. FASEB J. 13:727-34
80. Wickham TJ, Tzeng E, Shears LL, Roelvink PW, Li Y, Lee GM, Brough DE, Lizonova A, Kovesdi I. 1997. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J. Virol. 71:8221-29
81. Dmitriev I, Krasnykh V, Miller CR, Wang M, Kashentseva E, Mikheeva G, Belousova N, Curiel DT. 1998. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J. Virol. 72:9706-13
82. Ellerby HM, Arap W, Andrusiak R, Ellerby LM, Kain R, Del Rio G, Ruos lahti E, Bredesen DE, Pasqualini R. 1999. Anti-tumor activity of targeted pro-apoptotic peptides. Nat. Med. 5: 1032-38